Literature DB >> 3894973

Carmustine as a cause of acute nonlymphocytic leukemia.

M H Greene, J D Boice, T A Strike.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894973

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Treatments for astrocytic tumors in children: current and emerging strategies.

Authors:  Stanislaw R Burzynski
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 2.  Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.

Authors:  Ying-Wen Su; Ming-Chih Chang; Ming-Fu Chiang; Ruey-Kuen Hsieh
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 3.  Treatment-related myelodysplasia in patients with primary brain tumors.

Authors:  Joachim M Baehring; Peter W Marks
Journal:  Neuro Oncol       Date:  2012-03-29       Impact factor: 12.300

Review 4.  Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant.

Authors:  L R Rogers; N Janakiraman; C Kasten-Sportes; M L Rosenblum
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia.

Authors:  Marc C Chamberlain; Jeffrey Raizer
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

Review 6.  Acute leukemia following treatment of malignant glioma.

Authors:  J R Perry; M T Brown; J P Gockerman
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

Review 7.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

8.  Secondary hematological malignancies associated with temozolomide in patients with glioma.

Authors:  Hiroyuki Momota; Yoshitaka Narita; Yasuji Miyakita; Soichiro Shibui
Journal:  Neuro Oncol       Date:  2013-03-21       Impact factor: 12.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.